eNews
Home page > Comments


Comments

EU body backs Novartis' Galvus, Eucreas for diabetes indications

22.09.2012. | ZURICH (Reuters) - European regulators on Friday issued positive opinions for new indications of Novartis AG drugs Galvus and Eucreas in combination with other treatments for type 2 diabetes patients....


Оставите Ваш коментр
*Име:

Е-пошта:


*Ваш коментар:
:) :D ;) B-) :P :-o :( x-(

*Сигурносни број: